Long-term outcomes of elosulfase alfa enzyme replacement therapy in adults with MPS IVA: a sub-analysis of the Morquio A Registry Study (MARS).

Saved in:
Bibliographic Details
Title: Long-term outcomes of elosulfase alfa enzyme replacement therapy in adults with MPS IVA: a sub-analysis of the Morquio A Registry Study (MARS).
Authors: Stepien KM; Northern Care Alliance NHS Foundation Trust, Salford, UK. karolina.stepien@nca.nhs.uk., Burton BK; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA., Bober MB; Nemours/Alfred I. DuPont Hospital for Children, Wilmington, DE, USA., Campeau PM; CHU Sainte-Justine Research Center, Montreal, Quebec, Canada., Ellaway C; Sydney Children's Hospital Network, The Children's Hospital at Westmead, Westmead, Sydney, NSW, Australia., Bhattacharya K; Sydney Children's Hospital Network, The Children's Hospital at Westmead, Westmead, Sydney, NSW, Australia., Guffon N; Reference Centre of Inherited Metabolic Disease, Hospices Civils de Lyon, Lyon, France., Hinds D; BioMarin Pharmaceutical Inc., Novato, CA, USA., Hunt A; BioMarin Pharmaceutical Inc., Novato, CA, USA., Lail A; BioMarin Pharmaceutical Inc., Novato, CA, USA., Lin SP; MacKay Children's Hospital, Taipei, Taiwan., Magner M; Department of Pediatrics and Inherited Metabolic Disorders, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic., Murphy E; National Hospital for Neurology and Neurosurgery, London, UK., Reisewitz P; BioMarin Pharmaceutical Inc., Novato, CA, USA., Mitchell JJ; McGill University Health Centre, Montreal, Quebec, Canada.
Source: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2025 Oct 30; Vol. 20 (1), pp. 548. Date of Electronic Publication: 2025 Oct 30.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101266602 Publication Model: Electronic Cited Medium: Internet ISSN: 1750-1172 (Electronic) Linking ISSN: 17501172 NLM ISO Abbreviation: Orphanet J Rare Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41168830
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-term outcomes of elosulfase alfa enzyme replacement therapy in adults with MPS IVA: a sub-analysis of the Morquio A Registry Study (MARS).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stepien+KM%22">Stepien KM</searchLink>; Northern Care Alliance NHS Foundation Trust, Salford, UK. karolina.stepien@nca.nhs.uk.<br /><searchLink fieldCode="AU" term="%22Burton+BK%22">Burton BK</searchLink>; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Bober+MB%22">Bober MB</searchLink>; Nemours/Alfred I. DuPont Hospital for Children, Wilmington, DE, USA.<br /><searchLink fieldCode="AU" term="%22Campeau+PM%22">Campeau PM</searchLink>; CHU Sainte-Justine Research Center, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Ellaway+C%22">Ellaway C</searchLink>; Sydney Children's Hospital Network, The Children's Hospital at Westmead, Westmead, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Bhattacharya+K%22">Bhattacharya K</searchLink>; Sydney Children's Hospital Network, The Children's Hospital at Westmead, Westmead, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Guffon+N%22">Guffon N</searchLink>; Reference Centre of Inherited Metabolic Disease, Hospices Civils de Lyon, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Hinds+D%22">Hinds D</searchLink>; BioMarin Pharmaceutical Inc., Novato, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hunt+A%22">Hunt A</searchLink>; BioMarin Pharmaceutical Inc., Novato, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lail+A%22">Lail A</searchLink>; BioMarin Pharmaceutical Inc., Novato, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lin+SP%22">Lin SP</searchLink>; MacKay Children's Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Magner+M%22">Magner M</searchLink>; Department of Pediatrics and Inherited Metabolic Disorders, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Murphy+E%22">Murphy E</searchLink>; National Hospital for Neurology and Neurosurgery, London, UK.<br /><searchLink fieldCode="AU" term="%22Reisewitz+P%22">Reisewitz P</searchLink>; BioMarin Pharmaceutical Inc., Novato, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mitchell+JJ%22">Mitchell JJ</searchLink>; McGill University Health Centre, Montreal, Quebec, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101266602%22">Orphanet journal of rare diseases</searchLink> [Orphanet J Rare Dis] 2025 Oct 30; Vol. 20 (1), pp. 548. <i>Date of Electronic Publication: </i>2025 Oct 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101266602 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1750-1172 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217501172%22">17501172 </searchLink><i>NLM ISO Abbreviation: </i>Orphanet J Rare Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41168830
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13023-025-04064-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 548
    Titles:
      – TitleFull: Long-term outcomes of elosulfase alfa enzyme replacement therapy in adults with MPS IVA: a sub-analysis of the Morquio A Registry Study (MARS).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stepien KM
      – PersonEntity:
          Name:
            NameFull: Burton BK
      – PersonEntity:
          Name:
            NameFull: Bober MB
      – PersonEntity:
          Name:
            NameFull: Campeau PM
      – PersonEntity:
          Name:
            NameFull: Ellaway C
      – PersonEntity:
          Name:
            NameFull: Bhattacharya K
      – PersonEntity:
          Name:
            NameFull: Guffon N
      – PersonEntity:
          Name:
            NameFull: Hinds D
      – PersonEntity:
          Name:
            NameFull: Hunt A
      – PersonEntity:
          Name:
            NameFull: Lail A
      – PersonEntity:
          Name:
            NameFull: Lin SP
      – PersonEntity:
          Name:
            NameFull: Magner M
      – PersonEntity:
          Name:
            NameFull: Murphy E
      – PersonEntity:
          Name:
            NameFull: Reisewitz P
      – PersonEntity:
          Name:
            NameFull: Mitchell JJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 10
              Text: 2025 Oct 30
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1750-1172
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Orphanet journal of rare diseases
              Type: main
ResultId 1